Published in PLoS One on March 02, 2016
New directions using reporter enzyme fluorescence (REF) as a tuberculosis diagnostic platform. Tuberculosis (Edinb) (2016) 0.79
A Fluorescent Probe for Detecting Mycobacterium tuberculosis and Identifying Genes Critical for Cell Entry. Front Microbiol (2016) 0.75
Animal Models for Tuberculosis in Translational and Precision Medicine. Front Microbiol (2017) 0.75
Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol (2004) 36.25
A guide to choosing fluorescent proteins. Nat Methods (2005) 18.55
A clearer vision for in vivo imaging. Nat Biotechnol (2001) 10.49
Bright far-red fluorescent protein for whole-body imaging. Nat Methods (2007) 5.68
Evolution of new nonantibody proteins via iterative somatic hypermutation. Proc Natl Acad Sci U S A (2004) 4.37
Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity (2002) 3.48
A fluorescent variant of a protein from the stony coral Montipora facilitates dual-color single-laser fluorescence cross-correlation spectroscopy. Nat Biotechnol (2006) 2.45
Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol (2007) 2.31
Zebrafish embryos as a model host for the real time analysis of Salmonella typhimurium infections. Cell Microbiol (2003) 1.98
Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One (2010) 1.75
A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis. PLoS One (2013) 1.71
Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. Proc Natl Acad Sci U S A (2010) 1.51
A green to red photoconvertible protein as an analyzing tool for early vertebrate development. Dev Dyn (2007) 1.48
Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia (2006) 1.45
Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters. PLoS One (2010) 1.44
Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev (2010) 1.44
EFGP and DsRed expressing cultures of Escherichia coli imaged by confocal, two-photon and fluorescence lifetime microscopy. FEBS Lett (2000) 1.42
Infection of zebrafish embryos with intracellular bacterial pathogens. J Vis Exp (2012) 1.36
Advantages of multi-color fluorescent proteins for whole-body and in vivo cellular imaging. J Biomed Opt (2005) 1.35
Can we control tuberculosis in high HIV prevalence settings? Tuberculosis (Edinb) (2003) 1.29
Recent advances using green and red fluorescent protein variants. Appl Microbiol Biotechnol (2007) 1.27
Monitoring the trafficking of adoptively transferred antigen- specific CD8-positive T cells in vivo, using noninvasive luminescence imaging. Hum Gene Ther (2007) 1.23
Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence. J Antimicrob Chemother (2011) 1.20
Go with the glow: fluorescent proteins to light transgenic organisms. Trends Biotechnol (2006) 1.20
Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy. PLoS One (2012) 1.08
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging. J Antimicrob Chemother (2012) 1.02
Live imaging of fluorescent proteins in chordate embryos: from ascidians to mice. Microsc Res Tech (2006) 0.99
Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase. J Antimicrob Chemother (2013) 0.98
Identification of Mycobacterium marinum macrophage infection mutants. Microb Pathog (2006) 0.95
Identification of Mycobacterium avium genes that affect invasion of the intestinal epithelium. Infect Immun (2005) 0.95
A Mycobacterium marinum mel2 mutant is defective for growth in macrophages that produce reactive oxygen and reactive nitrogen species. Infect Immun (2006) 0.93
Visualization of xenotransplanted human rhabdomyosarcoma after transfection with red fluorescent protein. J Pediatr Surg (2006) 0.91
Stopping routine vaccination for tuberculosis in schools. BMJ (2005) 0.91
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother (2015) 0.85
Evaluation of DNA vaccination with recombinant adenoviruses using bioluminescence imaging of antigen expression: impact of application routes and delivery with dendritic cells. J Gene Med (2006) 0.85
Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds. Antimicrob Agents Chemother (2013) 0.83
Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosis. Antimicrob Agents Chemother (2014) 0.83